|

Teplizumab Clinical Trials

5 actively recruiting trials across 3 locations

No change since May 2026

Also known as: SAR446681, TZIELD

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Sanofi5

Indications

  • Diabetes5
  • Type 1 Diabetes3
  • Type 1 Diabetes Mellitus2

Other2 trials

Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes
Phase 2
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

Scottsdale, Arizona1 trial

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Scottsdale Clinical Trials- Site Number : 8400044

Phase 3

San Francisco, California1 trial

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

Investigational Site

Atlanta, Georgia1 trial

Long-Term Outcomes of Teplizumab in Routine Clinical Care

Investigational Site Number: 8400003

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.